Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
123
NCT00540358
A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer
Phase: Phase 2
Role: Collaborator
Start: Oct 31, 2007
Completion: Jun 30, 2010